296 related articles for article (PubMed ID: 12090811)
1. Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?
Rapoport SI; Bosetti F
Arch Gen Psychiatry; 2002 Jul; 59(7):592-6. PubMed ID: 12090811
[TBL] [Abstract][Full Text] [Related]
2. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder.
Bazinet RP; Rao JS; Chang L; Rapoport SI; Lee HJ
Biol Psychiatry; 2006 Mar; 59(5):401-7. PubMed ID: 16182257
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder.
Bazinet RP; Weis MT; Rapoport SI; Rosenberger TA
Psychopharmacology (Berl); 2006 Jan; 184(1):122-9. PubMed ID: 16344985
[TBL] [Abstract][Full Text] [Related]
4. Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?
Bazinet RP
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1104-9. PubMed ID: 19754461
[TBL] [Abstract][Full Text] [Related]
5. Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain.
Bosetti F; Rintala J; Seemann R; Rosenberger TA; Contreras MA; Rapoport SI; Chang MC
Mol Psychiatry; 2002; 7(8):845-50. PubMed ID: 12232777
[TBL] [Abstract][Full Text] [Related]
6. Antimanic therapies target brain arachidonic acid signaling: lessons learned about the regulation of brain fatty acid metabolism.
Lee HJ; Rao JS; Rapoport SI; Bazinet RP
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):239-46. PubMed ID: 18042366
[TBL] [Abstract][Full Text] [Related]
7. Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?
Rao JS; Lee HJ; Rapoport SI; Bazinet RP
Mol Psychiatry; 2008 Jun; 13(6):585-96. PubMed ID: 18347600
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain.
Bosetti F; Weerasinghe GR; Rosenberger TA; Rapoport SI
J Neurochem; 2003 May; 85(3):690-6. PubMed ID: 12694395
[TBL] [Abstract][Full Text] [Related]
9. Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat.
Bazinet RP; Rao JS; Chang L; Rapoport SI; Lee HJ
Psychopharmacology (Berl); 2005 Oct; 182(1):180-5. PubMed ID: 15986187
[TBL] [Abstract][Full Text] [Related]
10. Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers.
Chang MC; Contreras MA; Rosenberger TA; Rintala JJ; Bell JM; Rapoport SI
J Neurochem; 2001 May; 77(3):796-803. PubMed ID: 11331408
[TBL] [Abstract][Full Text] [Related]
11. Bipolar disorder and mechanisms of action of mood stabilizers.
Rapoport SI; Basselin M; Kim HW; Rao JS
Brain Res Rev; 2009 Oct; 61(2):185-209. PubMed ID: 19555719
[TBL] [Abstract][Full Text] [Related]
12. Mood-stabilizers target the brain arachidonic acid cascade.
Rao JS; Rapoport SI
Curr Mol Pharmacol; 2009 Jun; 2(2):207-14. PubMed ID: 20021459
[TBL] [Abstract][Full Text] [Related]
13. Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.
Rapoport SI
ACS Chem Neurosci; 2014 Jun; 5(6):459-67. PubMed ID: 24786695
[TBL] [Abstract][Full Text] [Related]
14. Chronic lamotrigine does not alter the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat: implications for the treatment of bipolar disorder.
Lee HJ; Rao JS; Chang L; Rapoport SI; Bazinet RP
Psychopharmacology (Berl); 2007 Sep; 193(4):467-74. PubMed ID: 17487474
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
Dunner DL
J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment.
Chang MC; Bell JM; Purdon AD; Chikhale EG; Grange E
Neurochem Res; 1999 Mar; 24(3):399-406. PubMed ID: 10215514
[TBL] [Abstract][Full Text] [Related]
17. Lithium decreases turnover of arachidonate in several brain phospholipids.
Chang MC; Grange E; Rabin O; Bell JM; Allen DD; Rapoport SI
Neurosci Lett; 1996 Dec; 220(3):171-4. PubMed ID: 8994220
[TBL] [Abstract][Full Text] [Related]
18. Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain.
Ghelardoni S; Tomita YA; Bell JM; Rapoport SI; Bosetti F
Biol Psychiatry; 2004 Aug; 56(4):248-54. PubMed ID: 15312812
[TBL] [Abstract][Full Text] [Related]
19. Brain arachidonic acid uptake and turnover: implications for signaling and bipolar disorder.
Duncan RE; Bazinet RP
Curr Opin Clin Nutr Metab Care; 2010 Mar; 13(2):130-8. PubMed ID: 20145439
[TBL] [Abstract][Full Text] [Related]
20. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.
Shimshoni JA; Basselin M; Li LO; Coleman RA; Rapoport SI; Modi HR
Biochim Biophys Acta; 2011 Mar; 1811(3):163-9. PubMed ID: 21184843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
